Diagnosing EoE can be tricky. There’s no single test, and symptoms like trouble swallowing, chest pain, and heartburn can mimic other conditions. Often, an endoscopy with biopsies, where a tiny tissue ...
Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a ...
Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission ...
SNY's reasonable valuation, rising estimates, improving top line and positive pipeline progress are good enough reasons to ...
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology to ...
Before the FDA approved AstraZeneca’s Fasenra, Nucala was the only therapy for treating eosinophilic granulomatosis with ...
The FDA has approved Fasenra® (benralizumab) for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis.
More than half (60%) of patients in latest trial reached active remission and 41% stopped taking corticosteroid entirely.
A condition known as eosinophilic esophagitis, or EoE, affects one in 1,500 kids. They actually have an allergic reaction ...
Fasenra was approved in 2017 but AZ came up short in its attempts to expand its label to chronic obstructive pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback